Rochester RHIO upgrades its Image Exchange program

| | Health Exec | Digital Transformation

The Rochester Regional Health Information Organization (RHIO) is upgrading its Image Exchange to allow healthcare providers improved access to diagnostic images.

The New York RHIO will benefit from new features, such as the capability for access to emergent images before a radiologist has issued a report; image display with an onboard “zero footprint” viewer that lets physicians analyze details and make side-by-side comparisons; and faster image retrieval.

“It lets specialists and primary care doctors see not just radiology reports but the images on which those reports are based,” explained Ted Kremer, executive director of the Rochester RHIO.

Related Content

2024 in AI weirdness: ‘Insane’ ChatGPT and mutant rat genitals were only the beginning
10 signs AI is ‘eating the world (of venture capital)’
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy
Healthcare AI regulation needs nuance, balance: Research review
ICU diary-keeping: There’s an AI for that
Stanford HAI lookback: Best-read blog posts of 2024

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.